Next Gen Jane

Devastating female reproductive disorders can take up to a decade to identify today based on: Spun out of Harvard University, an elegant and simple consumer-facing technology platform that allows users to collect a noninvasive, enriched, natural biopsy from the body with a familiar household product, preserve nucleic acids and other analytes important for disease detection, and ship them off to a lab for in-depth sequencing and analysis. The company's smart tampon platform replaces the conventional standard of care with an easy to use, consumer friendly technology that allows women everywhere to gather the data they need to proactively manage their reproductive health. By developing genomic classifiers for specific disease states through ongoing clinical studies, NextGen Jane hopes to enable earlier diagnosis of reproductive disorders such as Endometriosis and Cervical Cancer.